Alpha Tau Medical (DRTS) Interest & Investment Income (2021 - 2026)
Alpha Tau Medical (DRTS) reported Interest & Investment Income of $9.6 million for Q1 2026, up 1445.95% on a YoY basis from $623370.9 in Q1 2025, and up 1445.95% sequentially from -$716000.0 in Q1 2025.
Alpha Tau Medical (DRTS) Interest & Investment Income (2021 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has 5 years of Interest & Investment Income data on file, last reported at $9.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 1445.95% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 136.57% YoY), and the FY2025 full-year result was $218000.0, up 105.07% from the prior year.
- Interest & Investment Income improved to $9.6 million in Q1 2026, from -$716000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $17.0 million in Q1 2022 to a low of -$6.0 million in Q2 2022.
- A 4-year average of $1.4 million and a median of -$716000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income sank 3002.7% in 2022 and surged 1445.95% in 2026, its largest moves.
- Tracing DRTS's Interest & Investment Income over 4 years: stood at -$4.6 million in 2022, then jumped by 89.59% to -$478000.0 in 2023, then slumped by 49.79% to -$716000.0 in 2025, then surged by 1445.95% to $9.6 million in 2026.
- Business Quant data shows DRTS's Interest & Investment Income at $9.6 million in Q1 2026, -$716000.0 in Q1 2025, and -$478000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | 9.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64 Mn |
| Mar 31, 2025 | -716,000.00 |
| Mar 31, 2023 | -478,000.00 |
| Dec 31, 2022 | -4.59 Mn |
| Sep 30, 2022 | -4.74 Mn |
| Jun 30, 2022 | -6.02 Mn |
| Mar 31, 2022 | 16.96 Mn |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 3.49 Mn |